News Focus
News Focus
Replies to #53155 on Biotech Values
icon url

go seek

10/03/07 11:40 PM

#53175 RE: DewDiligence #53155

Quiz, i don't know...

to gather additional safety and efficacy data vs Hepsera?
icon url

dewophile

10/04/07 9:43 AM

#53189 RE: DewDiligence #53155

because of the known high rate of relapse after discontinuation of drug (except in the rare case of HBSAg seroconversion) in e Ag- patients

(pts with sustained eAg seroconversion have a good likelihood of sustained suppression off drug so this arm is eligible for assessment of "svr")